First Time Loading...

CanSino Biologics Inc
SSE:688185

Watchlist Manager
CanSino Biologics Inc Logo
CanSino Biologics Inc
SSE:688185
Watchlist
Price: 53.97 CNY 0.78% Market Closed
Updated: May 7, 2024
Section:
 

Wall Street
Price Targets

Price Targets Summary
CanSino Biologics Inc

Wall Street analysts forecast CanSino Biologics Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CanSino Biologics Inc is 70.7 CNY with a low forecast of 70 CNY and a high forecast of 72.78 CNY.

Lowest Forecast
Wall Street Target
70 CNY
30% Upside
Average Forecast
Wall Street Target
70.7 CNY
31% Upside
Highest Forecast
Wall Street Target
72.78 CNY
35% Upside
Lowest
Price Target
70 CNY
30% Upside
Average
Price Target
70.7 CNY
31% Upside
Highest
Price Target
72.78 CNY
35% Upside
CanSino Biologics Inc Competitors:
Price Targets
ALKEM
Alkem Laboratories Ltd
4% Downside
H
300086
Honz Pharmaceutical Co Ltd
374% Upside
C
600062
China Resources Double-Crane Pharmaceutical Co Ltd
13% Upside
FULC
Fulcrum Therapeutics Inc
76% Upside
ALKEM
Alkem Laboratories Ltd
4% Downside
H
300086
Honz Pharmaceutical Co Ltd
374% Upside
C
600062
China Resources Double-Crane Pharmaceutical Co Ltd
13% Upside
FULC
Fulcrum Therapeutics Inc
76% Upside
SIGA
SIGA Technologies Inc
70% Upside
6622
Zhaoke Ophthalmology Ltd
418% Upside
JBCHEPHARM
J B Chemicals and Pharmaceuticals Ltd
1% Downside
185750
Chong Kun Dang Pharmaceutical Corp
38% Upside

Revenue
Forecast

Revenue Estimate
CanSino Biologics Inc

The compound annual growth rate of CanSino Biologics Inc's revenue for the next 3 years is 70%.

N/A
Past Growth
70%
Estimated Growth
Estimates Accuracy
-31%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
CanSino Biologics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
CanSino Biologics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
98%
Average Beat
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CanSino Biologics Inc's stock price target?
Price Target
70.7 CNY

According to Wall Street analysts, the average 1-year price target for CanSino Biologics Inc is 70.7 CNY with a low forecast of 70 CNY and a high forecast of 72.78 CNY.

What is CanSino Biologics Inc's Revenue forecast?
Projected CAGR
70%

The compound annual growth rate of CanSino Biologics Inc's revenue for the next 3 years is 70%.

ALPHA SPREAD
Join more than 135,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.